Ernexa Therapeutics (ERNA) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q2 2025
Q4 2025
Q2 2026
-6.95
-4.84
-2.72
-0.61

Details

Expected EPS
-1.95
Actual EPS
-6.95
Surprise EPS
-5
Surprise Percent
-256.41%

Description

⁨Ernexa Therapeutics⁩ (⁦ERNA⁩) has reported earnings of ⁦-6.95⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts